Moderna Inc (MRNA)
39.80
-2.34
(-5.55%)
USD |
NASDAQ |
Nov 14, 16:00
39.38
-0.42
(-1.06%)
After-Hours: 18:13
Moderna Cash and Short Term Investments (Quarterly): 6.867B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.867B |
| June 30, 2024 | 8.488B |
| March 31, 2024 | 8.523B |
| December 31, 2023 | 8.604B |
| September 30, 2023 | 7.573B |
| June 30, 2023 | 8.459B |
| March 31, 2023 | 8.923B |
| December 31, 2022 | 9.902B |
| September 30, 2022 | 8.348B |
| June 30, 2022 | 7.897B |
| March 31, 2022 | 10.12B |
| December 31, 2021 | 10.73B |
| September 30, 2021 | 8.906B |
| Date | Value |
|---|---|
| June 30, 2021 | 7.99B |
| March 31, 2021 | 7.735B |
| December 31, 2020 | 4.608B |
| September 30, 2020 | 3.276B |
| June 30, 2020 | 2.717B |
| March 31, 2020 | 1.218B |
| December 31, 2019 | 1.103B |
| September 30, 2019 | 1.059B |
| June 30, 2019 | 1.070B |
| March 31, 2019 | 1.109B |
| December 31, 2018 | 1.521B |
| September 30, 2018 | 1.072B |
| December 31, 2017 | 756.03M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.103B
Minimum
Dec 2019
10.73B
Maximum
Dec 2021
7.099B
Average
8.169B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 3.518B |
| Pfizer Inc | 9.952B |
| Merck & Co Inc | 14.59B |
| Novavax Inc | 1.050B |
| Vertex Pharmaceuticals Inc | 6.524B |